VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM:IXI), the brain health company, announced recently that they are jointly leasing 2,190 sq. ft. of office space in New Hope, which is “strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania.” The office will be located at 220 Union Square Drive, says the company, and staffing for the office will begin immediately.
“This new office will establish a presence for the international commercial and operational alliance VirtualScopics and IXICO have formed,” explained Erik Jensen, Vice President, Global Business Development and Marketing of VirtualScopics. “It is in close proximity to many of our respective large pharma clients, including one of the two new customers VirtualScopics recently won awards from this year who are among the top 15 big pharma organizations.
“Opening this office together is an important initiative of our strategic alliance, and will allow us to work collaboratively, side by side with our colleagues at IXICO on numerous pharma projects,” added Jensen. “The New Hope office will provide a base of operations for project managers to meet with clinical trial managers, members of the business development team to meet with new and existing clients, as well as for human resource personnel to recruit new talent to support our clients’ upcoming clinical trials.”
“IXICO is delighted to be sharing the New Hope office with VirtualScopics,” commented John Hall, Vice President, Business Development. “This provides IXICO’s first premises in North America in a location close to many of our pharmaceutical customers, and enables us to better serve the needs of our current and future customers, and facilitates a closer working relationship within our alliance.”